Custom Search

News

Thursday 01 September 2005

Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.

By: Italiano A, Jardin F, Peyrade F, Saudes L, Tilly H, Thyss A.

Haematologica 2005 Sep;90(9):1281-3

Treatment of very old patients with non-Hodgkin's lymphoma remains controversial. Indeed, patients over 80 years old are usually not included in trials. We show here that addition of rituximab to reduced-dose CHOP chemotherapy seems to be a good compromise between toxicity and efficacy, allowing clinicians to treat very elderly patients with a curative intent.

Use of this site is subject to the following terms of use